Sun, Nuo https://orcid.org/0000-0001-9829-8172
Barta, Hayley
Chaudhuri, Samhita https://orcid.org/0000-0003-3845-0448
Chen, Kangxuan
Jin, Jiacheng
Luo, Hongke
Yang, Mingchong https://orcid.org/0000-0003-0912-8417
Krigman, Judith
Zhang, Ruohan
Sanghvi, Shridhar
Sekine, Shiori https://orcid.org/0000-0001-9962-833X
Sanders, Hannah
Kolonay, Dominic
Patel, Mudra
Baskin, Kedryn https://orcid.org/0000-0003-3187-9655
Singh, Harpreet https://orcid.org/0000-0002-6135-1897
Zhang, Pengyi
Xin, Gang
Finkel, Toren https://orcid.org/0000-0002-0726-3546
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL135051, HL160581)
Article History
Received: 16 April 2024
Accepted: 29 May 2025
First Online: 1 July 2025
Competing interests
: T.F. is a co-founder and stockholder in Generian Pharmaceuticals and Coloma Therapeutics. The other authors declare no competing interests.